https://www.frontiersin.org/journals/genetics/articles/10.3389/fgene.2023.952379/full
Frontiers | Review the progression of ovarian clear cell carcinoma from the perspective of genomics...
Ovarian clear cell carcinoma (OCCC) is a rare subtype of epithelial ovarian cancer with unique molecular characteristics, specific biological and clinical be...
ovarian clear cell carcinomathe progression
https://pmc.ncbi.nlm.nih.gov/articles/PMC4632203/
Ovarian Clear Cell Carcinoma, Outcomes by Stage: The MSK Experience - PMC
Ovarian clear cell carcinomas (OCCC) are rare, and uncertainty exists as to the optimal treatment paradigm and validity of the FIGO staging system, especially...
ovarian clear cell carcinomaby stageoutcomes
https://www.cancer.gov/research/participate/clinical-trials-search/v?id=NCI-2023-07922&r=1
Dostarlimab and LB-100 for the Treatment of Patients with Recurrent Ovarian Clear Cell Carcinoma,...
Dostarlimab and LB-100 for the Treatment of Patients with Recurrent Ovarian Clear Cell Carcinoma, Peritoneal, or Fallopian Tube Cancer
https://www.news-medical.net/news/20150330/CASI-receives-CFDA-approval-for-ENMD-2076-Phase-2-clinical-trial-in-ovarian-clear-cell-carcinoma.aspx
CASI receives CFDA approval for ENMD-2076 Phase 2 clinical trial in ovarian clear cell carcinoma
Jun 20, 2019 - CASI Pharmaceuticals, Inc., a biopharmaceutical company dedicated to the acquisition, development and commercialization of innovative therapeutics addressing...